Is LBPH or DIVO a better dividend investment in 2026?

LBPH currently yields 3.33% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: DIVO offers higher current income.

What is the dividend yield difference between LBPH and DIVO?

LBPH has a forward dividend yield of 3.33% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 3.29 percentage points.

Home › Compare › LBPH vs DIVO

LBPH vs DIVO: Dividend Comparison 2026

LBPH yields 3.33% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DIVO wins by $6.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

LBPH

● Live price

3.33%

Share price

$59.98

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.8K

Annual income

$413.26

Full LBPH calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — LBPH vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LBPH	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LBPH + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LBPH pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBPH

Annual income on $10K today (after 15% tax)

$283.43/yr

After 10yr DRIP, annual income (after tax)

$351.27/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, DIVO beats the other by $505.93/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBPH + DIVO for your $10,000?

LBPH: 50%DIVO: 50%

100% DIVO50/50100% LBPH

Portfolio after 10yr

$27.9K

Annual income

$710.87/yr

Blended yield

2.55%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on LBPH right now

LBPH

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$61.00

+1.7% upside vs current

Range: $16.00 — $90.00

Altman Z

63.6

Piotroski

3/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBPH buys

DIVO buys

No recent congressional trades found for LBPH or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLBPHDIVO

Forward yield	3.33%	6.62% ✓
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$24.8K	$31.0K ✓
Annual income after 10y	$413.26	$1,008.47 ✓
Total dividends collected	$3.8K	$8.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: LBPH vs DIVO ($10,000, DRIP)

Year	LBPH Portfolio	LBPH Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$11,033	$333.44	$11,362	$661.96	$329.00 → DIVO
2	$12,150	$343.84	$12,860	$702.91	$710.00 → DIVO
3	$13,354	$353.85	$14,504	$743.56	$1.1K → DIVO
4	$14,652	$363.48	$16,303	$783.73	$1.7K → DIVO
5	$16,051	$372.73	$18,268	$823.31	$2.2K → DIVO
6	$17,556	$381.59	$20,408	$862.17	$2.9K → DIVO
7	$19,175	$390.07	$22,737	$900.20	$3.6K → DIVO
8	$20,915	$398.17	$25,266	$937.31	$4.4K → DIVO
9	$22,785	$405.89	$28,008	$973.42	$5.2K → DIVO
10	$24,793	$413.26	$30,977	$1,008.47	$6.2K → DIVO

LBPH vs DIVO: Complete Analysis 2026

LBPH — Stock

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Full LBPH Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this LBPH vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBPH vs SCHD LBPH vs JEPI LBPH vs O LBPH vs KO LBPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.